عرض تفاصيل البحث

ادناه جميع التفاصيل الخاصة بالبحث المطلوب عرضه. توفر هذه المنصة معلومات اساسية حول البحث, لمزيد من التفاصيل يرجى متابعة التصفح من خلال الضغط على الرابط الاصلي للبحث او رابط DOI.

عنوان البحث
Detection Of The Antibiotic Susceptibility Against Proteus Species And Escherichia Coli Isolated From Patients With Ear Infections
عنوان المجلة
International Journal Of Drug Delivery Technology
ISSN-0975-4415
تفاصيل النشر
سنة النشر - 2022 / الفهرس الاصلي للمجلة - 12 : 1 (عدد الصفحات 4)
تصنيف البحث
Microbiology - المجموعة الطبية
رابط DOI
#
البحث والاستدامة
الهدف 3 – الصحة الجيدة والرفاه   المزيد حول هذا الهدف
البحث والمجتمع
نعم , يدعم

اسم الباحثجهة الانتساببلد الباحث
Ehasn F. Hussein Department of Pathological Analyses/College of Science/University of Sumer Iraq

Introduction: Infections of the ear effect all ages especially infants and young and can be divided into two main forms such as otitis media and otitis externs. Ear infections associate with several types of pathogenic microorganism, replicate of antibiotic uses, age and health care. The most prevalence pathogenic bacteria of ear infections are Proteus spp and Escherichia coli. The resistance of the antibiotic represents a biggest problem to the human health. Methods: The samples of ear swabs are collected with sterile wooden sticks and the sterile container. This for isolation and detection of the E. coli, Proteus spp and Acinitobacter spp through using the biochemical tests and the VITEK 2 system. And then determine the antibiotic activity patterns against these bacteria through use the disc diffusion method on the plates of Moller Hinton ager by many antibiotic types. Results: Among all ear swab samples the percentage of positive bacterial growth is 33.333 %, and the percentage of both Proteus spp and E. coli equal to 20%. The females are more infective with infect percent equal to 60% than males, which equal to 40%. The Antibiotic susceptibility patterns show Azithromycin, Gentamycin, Amikacin, Imepinem and Meropenime have activity against Proteus spp. Whereas Cefoxitin, Ciprofloxacin, Levofloxacin, Ceftriaxone, Meropenime, Amkacin and Gentamycin have activity against E. coli. And Pipicarcillin/Tazobactam, Cefazalin, Cefepime and Imepinem have activity against Acinitobacter spp.